Economic outcomes of nutritional interventions with functional bioactive compounds

[1]  R. Cherecheș,et al.  Use and effectiveness of behavioural economics in interventions for lifestyle risk factors of non-communicable diseases: a systematic review with policy implications , 2018, Perspectives in public health.

[2]  D. Soffer,et al.  Review of Cardiometabolic Effects of Prescription Omega-3 Fatty Acids , 2017, Current Atherosclerosis Reports.

[3]  H. Gage,et al.  The effectiveness and cost-effectiveness of plant sterol or stanol-enriched functional foods as a primary prevention strategy for people with cardiovascular disease risk in England: a modeling study , 2017, The European Journal of Health Economics.

[4]  Jared G. Carlberg,et al.  Canadian Potential Healthcare and Societal Cost Savings from Consumption of Pulses: A Cost-Of-Illness Analysis , 2017, Nutrients.

[5]  F. van der Haar,et al.  The Use and Interpretation of Sodium Concentrations in Casual (Spot) Urine Collections for Population Surveillance and Partitioning of Dietary Iodine Intake Sources , 2016, Nutrients.

[6]  Stacey Fuller,et al.  New Horizons for the Study of Dietary Fiber and Health: A Review , 2016, Plant Foods for Human Nutrition.

[7]  M. Maziarz,et al.  Bioactive Plant Metabolites in the Management of Non-Communicable Metabolic Diseases: Looking at Opportunities beyond the Horizon , 2015, Metabolites.

[8]  Leila Posenato Garcia,et al.  Resenha do livro Saúde Brasil 2014: uma análise da situação de saúde e das causas externas , 2015 .

[9]  Jared G. Carlberg,et al.  Cost-of-illness analysis reveals potential healthcare savings with reductions in type 2 diabetes and cardiovascular disease following recommended intakes of dietary fiber in Canada , 2015, Front. Pharmacol..

[10]  O. D. Rangel-Huerta,et al.  A Systematic Review of the Efficacy of Bioactive Compounds in Cardiovascular Disease: Phenolic Compounds , 2015, Nutrients.

[11]  J. Schmier,et al.  Cost Savings of Reduced Constipation Rates Attributed to Increased Dietary Fibre Intakes in Europe: A Decision-Analytic Model , 2015 .

[12]  F. Hu,et al.  Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies , 2014, BMJ : British Medical Journal.

[13]  J. Schmier,et al.  Cost savings of reduced constipation rates attributed to increased dietary fiber intakes: a decision-analytic model , 2014, BMC Public Health.

[14]  Jared G. Carlberg,et al.  Health economics and nutrition: a review of published evidence. , 2012, Nutrition reviews.

[15]  B. Arondekar,et al.  Estimating health and economic benefits from using prescription omega-3 fatty acids in patients with severe hypertriglyceridemia. , 2011, The American journal of cardiology.

[16]  L. Niskanen,et al.  Health economic consequences of reducing salt intake and replacing saturated fat with polyunsaturated fat in the adult Finnish population: estimates based on the FINRISK and FINDIET studies , 2011, European Journal of Clinical Nutrition.

[17]  Jared G. Carlberg,et al.  Economic valuation of the potential health benefits from foods enriched with plant sterols in Canada , 2010, Food & nutrition research.

[18]  J. Hutton,et al.  Nutrition economics – characterising the economic and health impact of nutrition , 2010, British Journal of Nutrition.

[19]  Kirsten Bibbins-Domingo,et al.  Projected effect of dietary salt reductions on future cardiovascular disease. , 2010, The New England journal of medicine.

[20]  V. Fulgoni,et al.  Potential Health Benefits and Medical Cost Savings from Calorie, Sodium, and Saturated Fat Reductions in the American Diet , 2009, American journal of health promotion : AJHP.

[21]  H. Gylling,et al.  Plant stanol esters are potentially cost-effective in the prevention of coronary heart disease in men: Bayesian modelling approach , 2007, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[22]  L. Annemans,et al.  A Multi-Country Health Economic Evaluation of Highly Concentrated N-3 Polyunsaturated Fatty Acids in Secondary Prevention after Myocardial Infarction , 2006, PharmacoEconomics.

[23]  A. Gerber,et al.  Cost-benefit analysis of a plant sterol containing low-fat margarine for cholesterol reduction , 2006, The European Journal of Health Economics.

[24]  J. Schmier,et al.  The cost-effectiveness of omega-3 supplements for prevention of secondary coronary events. , 2006, Managed care.

[25]  R. Mensink,et al.  Metabolic effects of plant sterols and stanols (Review). , 2003, The Journal of nutritional biochemistry.

[26]  N. Novo,et al.  Health economics and health preference concepts to orthopedics practitioners , 2014, Acta ortopedica brasileira.

[27]  A. Feigl,et al.  The Global Economic Burden of Noncommunicable Diseases , 2012 .

[28]  F. Valagussa,et al.  Cost-Effectiveness Analysis of n-3 Polyunsaturated Fatty Acids (PUFA) after Myocardial Infarction , 2012, PharmacoEconomics.